Serum Institute
Serum Institute Gets Nod to Resume Clinical Trials of COVID-19 Vaccine
Indian Distributor of Drugs (DCGI) V.G. Somani gave Serum Institute of India (SII) permission to restart the clinical trial of the country’s Oxford COVID-19 vaccine candidate thus revoking its earlier decision to postpone all new recruitment for both phase two and three trials. However, the DCGI has imposed some requirements, such as taking special caution […]